Journal of Peking University(Health Sciences) ›› 2018, Vol. 50 ›› Issue (4): 740-742. doi: 10.3969/j.issn.1671-167X.2018.04.030

• Article • Previous Articles     Next Articles

Transurethral resection of prostate treatment for recurrence of a multilocular prostatic cystadenoma: a case report

YANG Wen-bo1, ZHANG Xiao-wei1, YANG Jian2, LI Qing1, XU Tao1, BAI Wen-jun1△   

  1. (1. Department of Urology, Peking University People’s Hospital, Beijing 100044, China; 2. Department of Urology, Shandong Sunshine Union Hospital, Weifang 261000, Shandong, China)
  • Online:2018-08-18 Published:2018-08-18
  • Contact: BAI Wen-jun E-mail:bai-wj@163.com

Abstract: Multilocular prostatic cystadenoma (MPC) is a rare benign tumor that originates from the prostate itself. MPC is usually characterized by large multilocular cysts located between the rectum and bladder. The clinical presentation includes obstructive voiding symptoms, such as poor stream, intermittency, sensation of incomplete emptying, acute urinary retention and sometimes constipation symptoms due to mechanical compression of the lower intestine. Most of the previously reported patients with MPC underwent open surgery. Although the natural history of MPC remains unknown, surgical excision may not always be necessary. Here we report the case of a 49-year-old male, treated by transurethral electroresection of prostate (TURP) for prostate cyst one and half years before.His biopsy of TURP showed benign prostatic tissue with no evidence of malignancy. However, the symptoms of urinary tract obstruction were obviously aggravated after the operation. Acute urinary retention occurred intermittently 3 times. In our hospital, his total prostate specific antigen (tPSA)was 5.440 μg/L,free prostate specific antigen (fPSA ) was 1.528 μg/L. After examination, it was considered as benign lesions clearly. In the operation of TURP, we found that the tumor was multilocular cystic. Histologically,the cell was mucus. Concerning the immunophenotype,CK5/6(+), p40(+), PSA(+), P504S(+), PAX2(-), PAX8(-), MUC1(+), MUC5ac(+), the results of special staining were as follows: AB(+), PAS(+).At the end of the follow up 3 months later, the routine semen analysis results showed that his semen volume was 3 mL and the sperm density and sperm mobility were normal. At the end of the follow up eight months later, the patient remained free of lower urinary tract symptoms and there were no signs of recurrence. His international prostate symptom score (I-PSS) had dropped from 32 to 4, and quality of life score (QOL) had dropped from 6 to 2. MPC is a rare benign tumor originating from the prostate. TURP may aggravate the symptoms of lower urinary tract obstruction in patients with MPC, and may be temporarily observed for some asymptomatic young and middle-aged patients.

Key words: Cystadenoma, Prostate, Multilocular

CLC Number: 

  •  
[1] ZHANG Fan,HUANG Xiao-juan,YANG Bin,YAN Ye,LIU Cheng,ZHANG Shu-dong,HUANG Yi,MA Lu-lin. Relationship between prostate apex depth and early recovery of urinary continence after laparoscopic radical prostatectomy [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 692-696.
[2] BAI Gao-chen,SONG Yi,JIN Jie,YU Wei,HE Zhi-song. Clinical efficacy of docetaxel combined with carboplatin in patients with metastatic castration-resistant prostate cancer [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 686-691.
[3] HAO Han,LIU Yue,CHEN Yu-ke,SI Long-mei,ZHANG Meng,FAN Yu,ZHANG Zhong-yuan,TANG Qi,ZHANG Lei,WU Shi-liang,SONG Yi,LIN Jian,ZHAO Zheng,SHEN Cheng,YU Wei,HAN Wen-ke. Evaluating continence recovery time after robot-assisted radical prostatectomy [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 697-703.
[4] Wen-qing LI,Si-mei REN,Xing-bo LONG,Yu-qing TIAN. Palmitoylome profiling indicates that androgens promote the palmitoylation of metabolism-related proteins in prostate cancer-derived LNCaP cells [J]. Journal of Peking University (Health Sciences), 2020, 52(2): 227-233.
[5] Kui-xia SUN,Cun-ling YAN,Zhi-yan LI,Ping LIU,Wei ZHANG,Qun HE. Clinical value of serum isoform [-2] proprostate-specific antigen and its derivatives in predicting aggressive prostate cancer [J]. Journal of Peking University (Health Sciences), 2020, 52(2): 234-239.
[6] Xiao WANG,Zhao-xing LI,Huan-fang FAN,Li-ying WEI,Xu-jin GUO,Na GUO,Tong WANG. A rare case of cystadenoma in the small intestine [J]. Journal of Peking University (Health Sciences), 2020, 52(2): 382-384.
[7] Ke LIU,Fan ZHANG,Chun-lei XIAO,Hai-zhui XIA,Yi-chang HAO,Hai BI,Lei ZHAO,Yu-qing LIU,Jian LU,Lu-lin MA. Low power seven-step two-lobe holmium laser enucleation of the prostate technique for surgical treatment of benign prostatic hyperplasia [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1159-1164.
[8] Kuan-gen ZHANG,Yu-he ZHOU,Ya-kun SHAO,Fang MEI,Jiang-feng YOU,Bei-ying LIU,Fei PEI. Novel tumor metastasis suppressorgene LASS2/TMSG1 S248A mutant promotes invasion of prostate cancer cells through increasing ATP6V0C expression [J]. Journal of Peking University(Health Sciences), 2019, 51(2): 210-220.
[9] ZHANG Fan, ZHANG Shu-dong, XIAO Chun-lei, HUANG Yi, MA Lu-lin. Perioperative parameters and prognosis analysis of patients aged 80 years or older treated with radical prostatectomy for prostate cancer [J]. Journal of Peking University(Health Sciences), 2018, 50(5): 822-827.
[10] ZHANG Fan, XIAO Chun-lei, ZHANG Shu-dong, HUANG Yi, MA Lu-lin. Relationship between recovery of urinary continence after laparoscopic radical prostatectomy and prostatic volume and intravesical prostatic protursion length [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 621-625.
[11] TANG Xu, ZHAO Wei-hong, SONG Qin-qin, YIN Hua-qi, DU Yi-qing, SHENG Zheng-zuo, WANG Qiang, ZHANG Xiao-wei, LI Qing, LIU Shi-jun, XU Tao. Influence of SOX10 on the proliferation and invasion of prostate cancer cells [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 602-606.
[12] ZOU Peng-cheng, YANG Yi-feng, XU Xiao-yan LIU Bei-ying, MEI Fang, YOU Jiang-feng, LIU Qi-chen, PEI Fei . Silencing of vacuolar ATPase c subunit ATP6V0C inhibits invasion of prostate cancer cells [J]. Journal of Peking University(Health Sciences), 2017, 49(6): 937-947.
[13] JI Guang-jie, HUANG Cong, SONG Gang, LI Xue-song, SONG Yi, ZHOU Li-qun. Predictive factor analysis of time to progression of castration-resistant prostate cancer after androgen deprivation therapy [J]. Journal of Peking University(Health Sciences), 2017, 49(4): 657-662.
[14] LAN Ke, YANG Wen-bo, ZHANG Xiao-wei, BAI Wen-jun, LI Qing, XU Tao. Application of flurbiprofen axetil in pain management associated during transrectal ultrasound-guided prostate biopsy [J]. Journal of Peking University(Health Sciences), 2017, 49(4): 643-647.
[15] LIU Zhuo, LUO Cheng, HU Shuai, FAN Yu, LIU Zhen-hua, YANG Xin-yu, SHEN Qi, LIU Li-bo, HAN Wen-ke, ZHOU Li-qun, YU Wei, HE Qun, ZHANG Qian, JIN Jie. Diagnosis and treatment of T1a-T1b prostate cancer [J]. Journal of Peking University(Health Sciences), 2016, 48(5): 812-816.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 456 -458 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 125 -128 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 135 -140 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 217 -220 .
[5] . [J]. Journal of Peking University(Health Sciences), 2009, 41(1): 52 -55 .
[6] . [J]. Journal of Peking University(Health Sciences), 2009, 41(1): 109 -111 .
[7] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 297 -301 .
[8] . [J]. Journal of Peking University(Health Sciences), 2009, 41(5): 599 -601 .
[9] . [J]. Journal of Peking University(Health Sciences), 2009, 41(5): 516 -520 .
[10] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 304 -309 .